IBB is ready to revisit the highs of 133 made in July 2015, after a 4x increase since 2011 which was the equivalent of the dot-com bubble.
Assuming that pandemic issues are going to be a recurring catalyst, biotech could be ready to take again the mantle of market leader from technology (maybe it is a relay?).
Anyway, it seems a cup-and-handle breakout from 130s is ready to go (supported by increased volume, and the fact the ATR is back to its highs).
Assuming that pandemic issues are going to be a recurring catalyst, biotech could be ready to take again the mantle of market leader from technology (maybe it is a relay?).
Anyway, it seems a cup-and-handle breakout from 130s is ready to go (supported by increased volume, and the fact the ATR is back to its highs).